|
⚲
|
| Keyboard |
| OBrien Christopher Flint
✚
|
|
|---|---|
| CIK # | 0001343124 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001343124] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OBrien Christopher Flint | |
| Neurocrine Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2018-02-06 | Tax withheld | 1,014 | $82.48 | 83,635 |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2018-02-05 | Grant | 9,250 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2018-02-05 | Sell | 1,500 | $83.01 | 124,515 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2018-02-05 | Sell | 1,113 | $83.40 | 92,824 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2018-01-16 | Sell | 1,750 | $79.14 | 138,495 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-11-02 | Option exercise | 45,299 | $8.66 | 392,289 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-11-02 | Sell | 7,518 | $69.71 | 524,080 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-11-02 | Option exercise | 7,518 | $8.65 | 65,031 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-11-02 | Sell | 45,299 | $69.71 | 3,157,793 |
|
Neurocrine Biosciences Inc NBIX
Incentive Stock Option · derivative
|
2017-11-02 | Option exercise | 14,049 | $8.66 | 121,664 |
|
Neurocrine Biosciences Inc NBIX
Non Qualified Stock Option · derivative
|
2017-11-02 | Option exercise | 7,518 | $8.65 | 65,031 |
|
Neurocrine Biosciences Inc NBIX
Non Qualified Stock Option · derivative
|
2017-11-02 | Option exercise | 31,250 | $8.66 | 270,625 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-10-02 | Option exercise | 6,925 | $8.65 | 59,901 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-10-02 | Sell | 6,925 | $61.04 | 422,702 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2017-10-02 | Option exercise | 6,925 | $8.65 | 59,901 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-09-05 | Option exercise | 52,817 | $8.66 | 457,395 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-09-05 | Sell | 52,817 | $57.50 | 3,036,978 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2017-09-05 | Option exercise | 52,817 | $8.66 | 457,395 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2017-07-27 | Option exercise | 8,734 | $8.65 | 75,549 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2017-07-27 | Option exercise | 8,734 | $8.65 | 75,549 |
| showing 20 of 131 most recent transactions | |||||